| Description | S07-1066, an aldo-keto reductase 1C3 (AKR1C3) inhibitor, enhances doxorubicin (DOX) cytotoxicity by selectively inhibiting AKR1C3-mediated reduction of DOX and reversing DOX resistance in cells with elevated AKR1C3 expression [1]. |
| molecular weight | 325.16 |
| Molecular formula | C16H11Cl2FO2 |
| CAS | 876625-29-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |